46.75.Z - Wholesale trade
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
58.29.Z - Publishing of other software
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | 1,6 | 2,7 | 69,9 |
Gross profit (loss) | 0,1 | 0,9 | 0,5 | -47,6 |
EBITDA | 0,1 | 0,8 | 0,5 | -42,9 |
Short time liabilities | 2,5 | 6,1 | 7,4 | 20,9 |
Other operating costs | 0 | 0,8 | 2,3 | 194,4 |
Equity capital | 1,1 | 1,8 | 2,2 | 18,7 |
Operating profit (EBIT) | 0,1 | 0,8 | 0,5 | -42,9 |
Assets | 4,2 | 8,1 | 9,7 | 19,9 |
Net profit (loss) | 0,1 | 0,7 | 0,3 | -54,5 |
Cash | 0,3 | 0,2 | 0,4 | 81,8 |
Net income from sale | 3,2 | 9,4 | 28,5 | 201,5 |
Liabilities and provisions for liabilities | 3,2 | 6,3 | 7,6 | 20,3 |
Working assets | 4,2 | 8,1 | 9,7 | 19,9 |
Other income costs | 0 | 0 | 0 | 181 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 5,2 | 41 | 15,7 | -25,3 |
Equity capital to total assets | 25,4 | 22,5 | 22,2 | -0,3 |
Gross profit margin | 2,9 | 10 | 1,7 | -8,3 |
EBITDA Margin | 2,9 | 9 | 1,7 | -7,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 280 | 236 | 95 | -141 |
Current financial liquidity indicator | 1.6968889236450195 | 1.3307405710220337 | 1.3196208477020264 | 0 |
Net dept to EBITDA | 6.8848700523376465 | 0.5578211545944214 | 0.63169264793396 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane